45 results
Page 2 of 3
POS AM
l19fg
3 Sep 21
Prospectus update (post-effective amendment)
4:31pm
S-8
EX-99.1
tjk46o6qxjk53l k2z
16 Jul 21
Registration of securities for employees
4:31pm
424B3
lbuugp0goq4idgjg1a
9 Apr 21
Prospectus supplement
4:36pm
F-1
km486nefdfyg0xta
1 Apr 21
Registration statement (foreign)
5:29pm
6-K
EX-99.1
yqhjpy mcvpbn1lgp
18 Mar 21
PainReform Provides Year-End Business Update and Reports Progress Towards
10:36am
20-F
ifbphbnd qtdaw05t
18 Mar 21
Annual report (foreign)
9:03am
20-F
EX-2.1
fhwfcqrj
18 Mar 21
Annual report (foreign)
9:03am
6-K
0f8ojbpbx1
9 Mar 21
PainReform Announces $6.0 Million Private Placement
4:15pm
6-K
EX-99.1
stxmkkk6epxm5v
19 Jan 21
Extraordinary General Meeting of Shareholders
4:35pm
6-K
EX-99.1
i8s86
4 Jan 21
PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110
4:16pm
424B3
q2q9ad50tjn
30 Sep 20
Prospectus supplement
4:42pm
6-K
EX-99.1
ihr9k n4ofxmk1480
30 Sep 20
Condensed Financial Statements
4:32pm
424B4
mzr11tg47a
2 Sep 20
Prospectus supplement with pricing info
4:09pm
F-1/A
e1gyixf4zxidbc1 w6hi
31 Aug 20
Registration statement (foreign) (amended)
6:06am
F-1/A
0o74mfub
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
8ge1 ifhs
10 Aug 20
Registration statement (foreign) (amended)
4:15pm
F-1/A
hcqr6o ajw
5 Aug 20
Registration statement (foreign) (amended)
1:26pm
F-1
EX-10.1
ldtm17 dn33p
30 Jun 20
Registration statement (foreign)
5:16pm
F-1
vq883ou t041a5ma
30 Jun 20
Registration statement (foreign)
5:16pm
F-1
EX-3.1
vu2uvz9hyi6s
30 Jun 20
Registration statement (foreign)
5:16pm